In Reply to Peñagarícano

Int J Radiat Oncol Biol Phys. 2021 Feb 1;109(2):641. doi: 10.1016/j.ijrobp.2020.08.066.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Bevacizumab
  • Chronic Disease
  • Glioma*
  • Humans
  • Neoplasm Recurrence, Local
  • Radiation Oncology*

Substances

  • Bevacizumab